Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Nepal J Epidemiol ; 11(3): 1053-1062, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34733567

RESUMEN

BACKGROUND: Dengue virus (DENV) continues to be an epidemic with high mortality rates. The clinical features, especially in the early phase of infection, are nonspecific and there is no single marker that can be reliably deployed for diagnostics. Further, serotype and genotype diversity is not clearly understood. This study was conceived to understand the performance characteristics of various diagnostic markers; serotype and genotype distribution is thus a vital requirement. METHODS: A subset of blood samples was obtained for all the clinically suspected Dengue cases during the period January to December 2017. The samples were tested for IgM and IgG antibodies and NS1 antigen by both ELISA and rapid tests. Real-time PCR, Conventional PCR and sequencing was performed based on the serology results. Correlation of the data with demographic and clinical details was used to analyze the performance characteristics of various tests. RESULTS: Clinical signs and symptoms could not predict dengue positivity due to lack of specific symptoms. The performance of IgM rapid test was found to be lower than the ELISA method (53.5% agreement). The NS1 rapid and NS1 ELISA tests were comparable (89.2% agreement). Majority of the infections were caused due to DEN-2 serotype and phylogenetic analysis revealed all the sequenced DEN-2 serotypes belong to Genotype IV. Three sequences were deposited into NCBI GenBank (GenBank accession number MW583116, MW579054 and MW579053). CONCLUSION: Our comprehensive data suggests that NS1 ELISA and PCR are best used in the early phase of dengue infection (< 5 days post-onset of fever), whereas IgM antibody detection is reliable only in the late phase. We also highlight the unreliable performance of rapid tests.

2.
Protein Expr Purif ; 155: 15-20, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30217599

RESUMEN

Strategic design and suitable purification techniques are of paramount importance in the production of recombinant proteins, if intended for use in a diagnostic assay. However, there is no single protocol that can be universally adopted for obtaining proteins in requisite quality and quantity across various platforms. In this study, we have targeted proteins of bluetongue virus (BTV), which is the causative agent of an arthropod-borne infectious disease in ruminants. Traditionally, serological diagnosis of the disease has rested upon either virus neutralization test or on an ELISA test that employed a recombinant structural (VP1, VP7) protein. Among the non-structural (NS) proteins of BTV, NS1 and NS3, are preferred candidate antigens in development of immuno-diagnostics as these provide the option for identifying recent/ongoing infection. However, the difficulty in production/purification of recombinant full length NS proteins of BTV in sufficient quantity and quality in various expression systems, due to inherent structural complexities, have restricted their wider applicability as immunodiagnostic reagents. To circumvent the difficulties associated with production/purification, we developed a novel NS1 and NS3 fusion gene (∼1302 bp) encoding for NS1 N-terminus (1M to G252 aa) and NS3 protein containing the N- and C-termini with a deletion of two hydrophobic domains along with intervening variable central domain (118A to A182 aa) of bluetongue virus 23. This construct was cloned, over-expressed and efficiently purified by single step affinity chromatography under unique denaturing/renaturing condition. The purified fusion protein was found suitable for detection of antibodies against BTV in an indirect ELISA (iELISA).


Asunto(s)
Virus de la Lengua Azul/genética , Proteínas no Estructurales Virales/genética , Animales , Lengua Azul/virología , Virus de la Lengua Azul/química , Clonación Molecular/métodos , Escherichia coli/genética , Expresión Génica , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/genética , Ovinos , Proteínas no Estructurales Virales/química
3.
Biologicals ; 49: 23-27, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28734743

RESUMEN

Foot and mouth disease is a highly contagious disease affecting cloven footed animals. Vaccination using inactivated virus is followed to control the disease. As the immune response conferred by the inactivated vaccine is short lived, there is a need for an alternate vaccine with increased duration of immunity. Inclusion of adjuvant which enhances B and T cell responses is one of the strategies to increase the duration of immune responses of the vaccine. Interleukin 15 is one such a cytokine which improves the cell mediated immune response and also involved in the maintenance of memory T and B cells. In the present communication, we evaluated the role of bovine IL-15 as an adjuvant to inactivated FMD vaccine in guinea pig model. Animals injected with FMD inactivated vaccine and IL-15 plasmid showed improved levels of neutralizing antibodies which were maintained up to 6 months (as the level of neutralizing antibodies is more >1.5 which is considered to give protection). Increased Th1 and Th2 responses (by measuring the level of IL-4 and IFN- gamma responses) were seen in IL-15 adjuvanted guinea pigs compared to animals injected with inactivated vaccine alone.


Asunto(s)
Adyuvantes Inmunológicos , Linfocitos B/inmunología , Virus de la Fiebre Aftosa , Inmunidad Celular/efectos de los fármacos , Interleucina-15 , Plásmidos , Linfocitos T/inmunología , Vacunas Virales , Adyuvantes Inmunológicos/genética , Adyuvantes Inmunológicos/farmacología , Animales , Células CHO , Bovinos , Cricetulus , Virus de la Fiebre Aftosa/química , Virus de la Fiebre Aftosa/inmunología , Cobayas , Inmunidad Celular/genética , Interleucina-15/genética , Interleucina-15/inmunología , Interleucina-15/farmacología , Plásmidos/genética , Plásmidos/farmacología , Vacunas de Productos Inactivados/química , Vacunas de Productos Inactivados/inmunología , Vacunas de Productos Inactivados/farmacología , Vacunas Virales/química , Vacunas Virales/inmunología , Vacunas Virales/farmacología
4.
J Soc Work Disabil Rehabil ; 5(3-4): 57-80, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17989011

RESUMEN

This paper, based on the report "The State and Civil Society in Disaster Response: An Analysis of the Tamil Nadu Tsunami Experience," (Srinivasan, Nagaraj, & Venkatesh, 2005) is essentially an empirical analysis of state and civil society responses in Tamil Nadu (India) to the tsunami of December 26, 2004. It examines interventions by state and non-state agencies, as well as people's experiences in the relief and rehabilitation phases to identify factors influencing both positive and negative outcomes of the tsunami response. Issues related to vulnerability and exclusion, equity, transparency and accountability in different sectors of disaster intervention are explored to highlight themes revolving around reach and efficacy of relief and recovery processes. These analyses bring out some interesting lessons with regard to the importance of institutional autonomy, non-politicized decision-making, and synergetic state-civil society interfaces in fostering inclusive, transparent and accountable rehabilitation processes. The roles played by institutional responsiveness and flexibility in shaping an effective disaster response also emerge very clearly from this study of the Tamil Nadu experience. Another crucial finding points to the need for detailed, reliable and disaggregated geo-demographic and socioeconomic records as a resource base for informing relief and rehabilitation interventions. The study draws extensively from the experiences and insights of people affected by, and involved in tsunami response, and from secondary knowledge resources available on the disaster.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...